Counterpoint Mutual Funds LLC Sells 371,155 Shares of Aveanna Healthcare Holdings Inc. $AVAH

Counterpoint Mutual Funds LLC cut its holdings in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 89.6% in the 1st quarter, HoldingsChannel reports. The firm owned 42,905 shares of the company’s stock after selling 371,155 shares during the quarter. Counterpoint Mutual Funds LLC’s holdings in Aveanna Healthcare were worth $276,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after buying an additional 2,400 shares during the last quarter. Quantbot Technologies LP purchased a new stake in Aveanna Healthcare during the second quarter worth about $43,000. Entropy Technologies LP purchased a new stake in Aveanna Healthcare during the third quarter worth about $107,000. Oxford Asset Management LLP bought a new stake in Aveanna Healthcare in the second quarter worth about $64,000. Finally, Oak Thistle LLC bought a new stake in Aveanna Healthcare in the fourth quarter worth about $101,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Aveanna Healthcare Price Performance

Aveanna Healthcare stock opened at $9.10 on Monday. Aveanna Healthcare Holdings Inc. has a one year low of $3.73 and a one year high of $10.32. The business has a fifty day moving average price of $7.36 and a 200-day moving average price of $7.56. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. The firm has a market capitalization of $1.98 billion, a P/E ratio of 7.71, a PEG ratio of 0.94 and a beta of 1.89.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The company had revenue of $647.91 million during the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare’s revenue for the quarter was up 15.9% on a year-over-year basis. As a group, equities research analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.65 EPS for the current year.

Insider Buying and Selling

In other Aveanna Healthcare news, insider Patrick A. Cunningham sold 125,000 shares of Aveanna Healthcare stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total transaction of $948,750.00. Following the completion of the transaction, the insider owned 212,755 shares of the company’s stock, valued at $1,614,810.45. The trade was a 37.01% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Robert M. Williams, Jr. sold 7,000,000 shares of the stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the completion of the sale, the insider directly owned 252,899 shares in the company, valued at approximately $1,578,089.76. The trade was a 96.51% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 31,305,664 shares of company stock worth $215,555,910 in the last 90 days. 5.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on AVAH shares. Barclays reduced their target price on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a research report on Monday, May 18th. Raymond James Financial upgraded Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price objective on the stock in a research note on Friday, March 20th. BMO Capital Markets reduced their price objective on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a report on Friday, March 20th. Royal Bank Of Canada raised Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price for the company in a research report on Wednesday, June 3rd. Finally, Truist Financial raised their target price on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a research report on Wednesday, May 20th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $10.50.

Aveanna Healthcare Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.